- Hong Kong
- /
- Healthcare Services
- /
- SEHK:8143
Good Fellow Healthcare Holdings Full Year 2025 Earnings: HK$0.017 loss per share (vs HK$0.029 loss in FY 2024)
Good Fellow Healthcare Holdings (HKG:8143) Full Year 2025 Results
Key Financial Results
- Revenue: HK$16.1m (down 59% from FY 2024).
- Net loss: HK$10.1m (loss narrowed by 41% from FY 2024).
- HK$0.017 loss per share (improved from HK$0.029 loss in FY 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Good Fellow Healthcare Holdings shares are down 2.4% from a week ago.
Risk Analysis
You should always think about risks. Case in point, we've spotted 5 warning signs for Good Fellow Healthcare Holdings you should be aware of, and 3 of them are a bit concerning.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SEHK:8143
Good Fellow Healthcare Holdings
An investment holding company, provides general hospital services in the People’s Republic of China.
Excellent balance sheet with slight risk.
Market Insights
Weekly Picks

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

AST SpaceMobile: The Boldest Direct-to-Cell Bet in Public Markets
Onto Innovation: The Advanced Packaging Chokepoint 51.3% undervalued intrinsic discount

Investment Analysis (May 2026)
Recently Updated Narratives

Making sense of 1.75 trillion IPO
SpaceX? Only Fast in - Fast out!

INDIAN OIL CORPORATION IS THE TITAN IN TRANSITION
Popular Narratives

Investment Analysis (May 2026)

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

Honeywell - The Demand-Side of the AI Infrastructure
Trending Discussion
